122 related articles for article (PubMed ID: 9568506)
1. Vascular density does not predict future metastatic disease in clinical stage 1 non-seminomatous germ cell tumours of the testis.
Maher TM; Lee AH
Histopathology; 1998 Mar; 32(3):217-24. PubMed ID: 9568506
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis.
Jones A; Fujiyama C; Turner K; Fuggle S; Cranston D; Turley H; Valtola R; Bicknell R; Harris AL
BJU Int; 2000 Jul; 86(1):80-6. PubMed ID: 10886088
[TBL] [Abstract][Full Text] [Related]
3. Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
Alexandre J; Fizazi K; Mahé C; Culine S; Droz JP; Théodore C; Terrier-Lacombe MJ
Eur J Cancer; 2001 Mar; 37(5):576-82. PubMed ID: 11290432
[TBL] [Abstract][Full Text] [Related]
4. Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours.
Costello AJ; Mortensen PH; Stillwell RG
Aust N Z J Surg; 1989 Feb; 59(2):119-22. PubMed ID: 2537616
[TBL] [Abstract][Full Text] [Related]
5. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
6. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
[TBL] [Abstract][Full Text] [Related]
7. [Management of stage I nonseminomatous germ cell tumours after orchiectomy].
Culine S; ;
Prog Urol; 2004 Dec; 14(6):1112-8. PubMed ID: 15751403
[TBL] [Abstract][Full Text] [Related]
8. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
9. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.
Freedman LS; Parkinson MC; Jones WG; Oliver RT; Peckham MJ; Read G; Newlands ES; Williams CJ
Lancet; 1987 Aug; 2(8554):294-8. PubMed ID: 2886764
[TBL] [Abstract][Full Text] [Related]
10. Orchidectomy after chemotherapy for patients with metastatic testicular germ cell cancer.
Geldart TR; Simmonds PD; Mead GM
BJU Int; 2002 Sep; 90(4):451-5. PubMed ID: 12175407
[TBL] [Abstract][Full Text] [Related]
11. Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease.
Olivarez D; Ulbright T; DeRiese W; Foster R; Reister T; Einhorn L; Sledge G
Cancer Res; 1994 May; 54(10):2800-2. PubMed ID: 7513256
[TBL] [Abstract][Full Text] [Related]
12. Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion".
Hoeltl W; Pont J; Kosak D; Honetz N; Marberger M
Br J Urol; 1992 Jan; 69(1):83-7. PubMed ID: 1737260
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
[TBL] [Abstract][Full Text] [Related]
14. Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.
Guney S; Guney N; Sonmez NC; Ergenekon E
Med Oncol; 2009; 26(2):136-42. PubMed ID: 18821067
[TBL] [Abstract][Full Text] [Related]
15. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
[TBL] [Abstract][Full Text] [Related]
16. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the testis followed by an overt malignant teratoma of the testis within 12 months.
Mark SD; Gowland SP; Arnold EP; McRae CU; Fitzharris BM
Aust N Z J Surg; 1994 Dec; 64(12):862-4. PubMed ID: 7980264
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
[TBL] [Abstract][Full Text] [Related]
19. Low sperm counts as a prognostic factor of progression in stage I non-seminomatous germ cell testicular tumours.
Ondrus D; Hornak M; Vrabec J
Br J Urol; 1988 Jul; 62(1):82-4. PubMed ID: 3408876
[TBL] [Abstract][Full Text] [Related]
20. Post-orchidectomy radiation therapy alone for patients with early stage non-seminomatous germ cell tumours of the testis.
Kearsley JH; Tripcony L
Australas Radiol; 1995 Feb; 39(1):47-53. PubMed ID: 7695528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
